계명대학교 의학도서관 Repository

악성 상대정맥 증후군에서 경피적 스텐트삽입술 및 항응고제 치료에도 불구하고 지속적으로 재발하는 스텐트 내 혈전증

Metadata Downloads
Author(s)
이상호심창우지호석이혜인최도일김흥태김현범이인준김선영
Publication Year
2016
Keyword
AnticoagulationEndovascular treatmentSuperior vena cava syndrome
Abstract
Endovascular treatment (EVT) including angioplasty and stenting is an effective treatment for superior vena cava (SVC) syndrome. Recurrence of SVC syndrome is mainly caused by tumor progression and occurs in around 20% after EVT, but sometimes venous thrombosis within stent accounts for recurrence of SVC syndrome. Anticoagulation after EVT is still a
controversial issue. In our case, a 73-year-old man with SVC syndrome caused by mediastinal metastasis from non-small cell lung cancer underwent endovascular stent followed by anticoagulation with low molecular weight heparin (LMWH), but symptomatic progression due to in-stent thrombosis necessitated the second procedure after two weeks. A
total of 4 sessions of endovascular stent and anticoagulation with LMWH, warfarin and rivaroxaban did not induce durable resolution of in-stent thrombosis. Our case suggests refractory in-stent thrombosis could develop despite of anticoagulation after endovascular stent for SVC syndrome.
Alternative Title
Intractable in stent thrombosis in malignant superior vena cava syndrome
Publisher
Keimyung University School of Medicine
Citation
Keimyung Medical Journal, Vol.35(1) : 73-78, 2016
Type
Article
URI
http://kumel.medlib.dsmc.or.kr/handle/2015.oak/15703
Authorize & License
  • AuthorizeOpen
Files in This Item:

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.